Guarding Against the Most Dangerous Emerging Pathogens: Insights from Evolutionary Biology

Emerging Infectious Diseases

Volumn 2, Issue 4, 1996, Pages 245-257

  Ewald, Paul W ^a  

^a AMHERST COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BACTERIUM; CLASSIFICATION; COMMUNICABLE DISEASE; CROSS INFECTION; DISEASE CARRIER; DISEASE TRANSMISSION; EPIDEMIC; EVOLUTION; GENETICS; HUMAN; MICROBIOLOGY; PATHOGENICITY; REVIEW; SEXUALLY TRANSMITTED DISEASE; VIROLOGY; VIRULENCE; VIRUS;

ANIMALS; BACTERIA; COMMUNICABLE DISEASES; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE VECTORS; EVOLUTION; HUMANS; SEXUALLY TRANSMITTED DISEASES; VIRULENCE; VIRUSES; WATER MICROBIOLOGY;

EID: 0030255037     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0204.960401     Document Type: Review

References (82)

1. Morse SM. Emerging viruses: defining the rules for viral traffic. Perspect Biol Med 1991;34:387-409.
2. Morse SM. Examining the origins of emerging viruses, In: Morse SM, editor. Emerging viruses. New York: Oxford, 1993;10-28.
3. Morse SM. Factors in the emergence of infectious disease. Emerging Infectious Diseases 1995;1:7-15.
4. Satcher D. Emerging infections: getting ahead of the curve. Emerging Infectious Diseases 1995; 1:1-6.
5. Henderson DA. Surveillance systems and intergovernmental cooperation. In: Morse SM, editor. Emerging viruses. New York: Oxford, 1993;283-9.
6. Holland J. Replication error, quasispecies populations, and extreme evolution rates of RNA viruses. In: Morse SM, editor. Emerging viruses. New York, Oxford, 1993;203-18.
7. Krause RM. Foreword. In: Morse SM, editor. Emerging viruses. New York: Oxford, 1993;xvii-xix.
8. McNeill WH. Patterns of disease emergence in history. In: Morse SM, editor. Emerging viruses. New York: Oxford, 1993;29-36.
9. Smith T. Parasitism and disease. Princeton: Princeton University Press, 1934.
10. Dubos R. Man adapting. New Haven, Conn: Yale University Press, 1965.
11. Burnet FM, White DO. Natural history of infectious disease, 4th ed. Cambridge: Cambridge University Press, 1972.
12. Thomas L. Notes of a biology-watcher: Germs. N Engl J Med 1972;247:553-5.
13. Levin S, Pimentel D. Selection of intermediate rates of increase in parasite-host systems. American Naturalist 1981;117:308-15.
14. Levin BR, Allison AC, Bremermann HJ, Cavalli-Sforza LL, Clarke BC, B Frentzel-Beyme R, et al. Evolution of parasites and hosts. Group report, In: Anderson RM, May RM, editors. Population Biology of Infectious Diseases. Berlin: Springer-Verlag 1982;213-43.
15. Anderson RM, May RM. Coevolution of hosts and parasites. Parasitology 1982;85:411-26.
16. Ewald PW. Host-parasite relations, vectors, and the evolution of disease severity. Annual Review of Ecology and Systematics 1983;14:465-85.
17. Ewald PW. Evolution of Infectious Disease. New York: Oxford University Press, 1994.
18. Morens DM, Marchette NJ, Chu MC, Halstead SB. Growth of dengue type-2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. Am J Trop Med Hyg 1991;45:644-51.
19. Gulig PA, Doyle TJ. The Salmonella typhimurium virulence plasmid increases the growth rate of salmonellae in mice. Infect Immun 1993;61:504-11.
20. Ewald PW. Transmission modes and the evolution of virulence, with special reference to cholera, influenza and AIDS. Human Nature 1991;2:1-30.
21. Åsjö B, Morfeldt-Månson L, Albert J, Biberfeld G, Karlsson A, Lidman K, et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986;334:660-2.
22. ChengMayer C, Seto D, Tateno M, Levy JA. Biologic features of HIV-1 that correlate with virulence in the host. Science 1988;240:80-2.
23. Albert J, Böttiger B, Biberfeld G, Fenyö EM. Replicative and cytopathic characteristics of HIV-2 and severity of infection. Lancet 1989;333:852-3.
24. Fenyö EM, Albert J, Åsjö B. Replicative capacity, cytopathic effects and cell tropism of HIV. AIDS 1989;3:S5-12.
25. Levy JA. Human immunodeficiency viruses and the pathogenesis of AIDS. JAMA 1989;261:2997-3006.
26. Tersmette M, Gruters RA, de Wolf F, de Goede REY, Lange JMA, Schellekens PTA, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates. J Virol 1989;63:2118-25.
27. Tersmette M, Lange JMA, de Goede REY, de Wolf F, Eefink Shaattenkerk JKM, Schellekens PTA, et al. Association beteween biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1989;333:983-5.
28. Ma X, Sakai K, Sinangil F, Golub E, Volsky DJ. Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells: Efficient virus entry followed by delayed expression of its RNA and protein. Virology 1990;176:184-94.
29. Schneweis K E, Kleim J-P, Bailly E, Niese D, Wagner N, Brackmann HH. Graded cytopathogenicity of the human immunodeficiency virus (HIV) in the course of HIV infection. Med Microbiol Immunol 1990;179:193-203.
30. Gruters RA, Terpstra FG, DeGoede REY, Mulder JW, DeWolf F, Schellekens PTA, et al. Immunological and virological markers in individuals progressing from seroconversion to AIDS. AIDS 1991;5:837-44.
31. Schellekens PTA, Tersmette M, Roos MTL, Keet RP, Dewolf F, Coutinho RA, et al. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS 1992;6:665-9.
32. Hirsch I, Salaun D, Brichacek B, Chermann JR. HIV-1 cytopathogenicity - genetic difference between direct cytotoxic and fusogenic effect. Virology 1992;186:647-54.
33. Koot M, Keet IPM, Vos AHV, DeGoede REY, Roos MTL, Coutinho, RA, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
34. Connor RI, Mohri H, Cao YZ, Ho DD. Increased viral burden and cytopathicity correlate temporally with CD4+ T lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67:1772-7.
35. Connor R I, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994;68:4400-8.
36. Fisher SG. Epidemiology: a tool for the study of human papillomavirus-related carcinogenesis. Intervirology 1994;37:215-25.
37. Puel J, Lheritier D, Guyader M, Izopet J, Briant L, Tricoire J, et al. Viral load and mother-to-infant HIV transmission. Lancet 1992;340:859.
38. Weiser B, Nachman S, Tropper P, Viscosi KH, Grimson R, Baxter G, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 1994;91:8037-41.
39. Kaye JN, Cason J, Pakarian F, Jewers R, Kell B, Bible J, et al. Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child. J Med Virol 1994;44:415-21.
40. Adjorloto-Johnson G, De Cock KM, Ekpini E, Vetter KM, Sibailly T, Brattegaard K, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994;272:462-6.
41. Ewald PW. Cultural vectors, virulence, and the emergence of evolutionary epidemiology. Oxford Surveys in Evolutionary Biology 1988;5:215-45.
42. Ewald PW. Waterborne transmission and the evolution of virulence among gastrointestinal bacteria. Epidemiol Infect 1991;106:83-119.
43. Weniger BG, Tansuphaswadikul S, Young NL, Pau CP, Lohsomboon P, Yindeeyoungyeon W, et al. Differences in immune function among patients infected with distinct Thailand HIV-1 strains, In: Proceedings of the Tenth International Conference on AIDS. Yokohama, Japan, 7-12 August 1994; Abstract O12C.
44. Kitayaporn D, Tansuphaswadikul S, Lohsomboon P, Pannachet K, Kaewkungwal J, Limpakarnjanarat K, et al. Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:77-82.
45. Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992;340:863-7.
46. Cao YZ, Qin LM, Zhang LQ, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
47. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-32.
48. Ewald PW. Evolution of mutation rate and virulence among human retroviruses. Phil Trans Roy Soc Lond, Ser B Biol Sci 1995;346:333-43.
49. Mitscherlich E, Marth EH. Microbial Survival in the Environment. Berlin, Germany: Springer-Verlag, 1984.
50. Meegan JM. Rift Valley fever in Egypt: an overview of the epizootics in 1977 and 1978. Contributions to Epidemiology and Biostatistics 1981;3:100-13.
51. House JA, Turell MJ, Mebus CA. Rift valley fever: present status and risk to the western hemisphere. Ann NY Acad Sci 1992;653:233-42.
52. Levine PH, Manns A, Jaffe ES, Colclough G, Cavallaro A, Reddy G, et al. The effect of ethnic differences on the pattern of HTLV-I-associated T-cell leukemia/lymphoma (HATL) in the United States. Int J Cancer 1994;56:177-81.
53. Franco EF, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995;172:756-63.
54. Weissman JB, Murton KI, Lewis JN, Friedemann CHT, Gangarosa EJ. Impact in the U.S. of the Shiga dysentery pandemic of Central America and Mexico: A review of surveillance data through 1972. J Infect Dis 1974;129:218-23.
55. Dixon RE. Effect of infections on hospital care. Ann Intern Med 1978;89:749-53.
56. Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate: A new need for vital statistics. Am J Epidemiol 1985;121:159-67.
57. Raju TNK, Kobler C. Improving handwashing habits in the newborn nurseries. Am J Med Sci 1991;302:355-8.
58. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Arch Intern Med 1995;155:1177-84.
59. Belnap D, O'Donnell JJ. Epidemic gastroenteritis due to Escherichia coli 0:111. J Pediat 1955;47:178-93.
60. Rountree P, Freeman BM. Infections caused by a particular phage type of Staphylococcus aureus. Med J Austr 1955;2:157-61.
61. Jessen O, Rosendal K, Bülow P, Faber V, Eriksen KR. Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia. N Engl J Med 1969;281:627-35.
62. Locksley RM, Cohen ML, Quinn TC, Tompkins LS, Coyle MB, Kirihara JM, et al. Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med 1982;97:317-24.
63. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artiga A, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Am J Respir Crit Care Med 1994;150:1545-9.
64. Holzman R, Florman A, Lyman M. Gentamicin resistant and sensitive strains of S. aureus. Factors affecting colonization and virulence for infants in a special care nursery. Am J Epidemiol 1980;112:352-61.
65. Gezon HM, Rogers KD, Thompson DJ, Hatch TF. Some controversial aspects in the epidemiology of hospital nursery staphylococcal infections. Am J Public Health 1960;50:473-84.
66. Gezon HM, Schaberg MJ, Klein JO. Concurrent epidemics of Staphylococcus aureus and group A streptococcus disease in a newborn nursery-control with penicillin G and hexachlorophene bathing. Pediatrics 1973;51:383-90.
67. Craven DE, Reed C, Kollisch N, DeMaria A, Lichtenberg D, Shen K, et al. A large outbreak of infections caused by a strain of Staphylococcus aureus resistant to oxacillin and aminoglycosides. Am J Med 1981;71:53-8.
68. Huebner J, Pier GB, Maslow JN, Muller E, Shiro H, Parent M, et al. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis 1994;169:526-31.
69. Donnenberg MS, Kaper JB. Enteropathogenic Escherichia coli. Infect Immun 1992;60:3953-61.
70. Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, et al. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest 1993;92:1412-7.
71. Franke J, Franke S, Schmidt H, Schwarzkopf A, Wieler LH, Baljer G, et al. Nucleotide sequence analysis of enteropathogenic Escherichia coli (EPEC) adherence factor probe and development of PCR for rapid detection of EPEC harboring virulence plasmids. J Clin Microbiol 1994;32:2460-3.
72. Schmidt H, Plaschke B, Franke S, Russman H, Schwarzkopf A, Heesemann J, et al. Differentiation in virulence patterns of Escherichia coli possessing eae genes. Med Microbiol Immunol 1994;183:23-31.
73. Spitz J, Yuhan R, Koutsouris A, Blatt C, Alverdy J, Gecht G. Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function. Am J Physiol 1995;268:G374-9.
74. Rogers KB, Koegler SJ. Inter-hospital cross-infection of epidemic infantile gastro-enteritis associated with type strains of Bacterium coli. Journal of Hygiene 1951;49:152-61.
75. Marcy SM: Microorganisms responsible for neonatal diarrhea, in Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders, 1976:892-978.
76. Saroglou G, Cromer M, Bisno AL. Methicillin-resistant Staphylococcus aureus:interstate spread of nosocomial infections with emergence of gentamicin-methicillin resistant strains. Infection Control 1980;1:81-9.
77. Pavillard R, Harvey K, Douglas D, Hewstone A, Andrew J, Collopy B, et al. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust 1982;1:451-4.
78. Lyon BR, Iuorio JL, May JW, Skurray RA. Molecular epidemiology of multiresistant Staphylococcus aureus in Australian hospitals. J Med Entomol 1984;17:79-89.
79. Gooch JJ, Britt EM. Staphylococcus aureus colonization and infection in newborn nursery patients. American Journal of Diseases of Children 1978;132:893-6.
80. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;96:11-6.
81. Keating JM. History of the yellow fever epidemic of 1878 in Memphis, Tennessee. Cincinnati, Ohio: Wrightson, 1879.
82. Daschner F. Infectious hazards in rooming-in systems. J Perinat Med 1984;12:3-6.